The absorption characteristics of the human cornea in ultraviolet-a crosslinking

Eye and Contact Lens

Volumn 36, Issue 2, 2010, Pages 77-80

  Koppen, Carina ^a,b   Gobin, Laure ^a,b   Tassignon, Marie José ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Corneal endothelium; Crosslinking; Ultraviolet A

Indexed keywords

COLLAGEN; DEXTRAN; RIBOFLAVIN;

ABSORPTION; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CROSS LINKING; DIAGNOSTIC IMAGING; HUMAN; HUMAN TISSUE; KERATOCONUS; PHOTOSENSITIZATION; PRIORITY JOURNAL; RISK ASSESSMENT; ULTRAVIOLET A RADIATION; VALIDATION STUDY;

ABSORPTION; CADAVER; CORNEA; DEBRIDEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM, CORNEAL; HUMANS; INSTILLATION, DRUG; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; SOLUTIONS; TIME FACTORS; TISSUE BANKS; ULTRAVIOLET RAYS;

EID: 77949457218     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e3181d0b74b     Document Type: Article

References (15)

1. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 2003;29:1780-1785.
2. Caporossi A, Baiocchi S, Mazotta C, et al. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced crosslinking of corneal collagen. J Cataract Refract Surg 2006;32:837-845.
3. Raiskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term results. J Cataract Refract Surg 2008;34:796-801.
4. Wittig-Silva C, Whiting M, Lamoureux E, et al. A randomized controlled trial of corneal collagen crosslinking in progressive keratoconus: Preliminary results. J Refract Surg 2008;24:S720-S725.
5. Grewal D, Brar G, Jain R, et al. Corneal collagen crosslinking using riboflavin and ultraviolet-A light for keratoconus. J Cataract Refract Surg 2009;35:425-432.
6. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135: 620-627.
7. Wollensak G, Spoerl E, Wilsch M, et al. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg 2003;29:1786-1790.
8. Spoerl E, Schreiber J, Hellmund K, et al. Untersuchungen zur Verfestigung der Hornhaut am Kaninchen. Ophthalmologe 2000;97:203-206.
9. Wollensak G, Spoerl E, Wilsch M, et al. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea 2004;23: 43-49.
10. Kolozsvari L, Nogradi A, Hopp B, et al. UV absorbance of the human cornea in the 240- to 400-nm range. Invest Ophthalmol Vis Sci 2002;43: 2165-2168.
11. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin crosslinking of the cornea. Cornea 2007;26:385-389.
12. Pinelli R. Corneal collagen cross-linking with riboflavin: Results at six months follow-up in 20 eyes. Presented at XXIV Congress of the ESCRS, Italy, 2006.
13. Boettner EA, Wolter JR. Transmission of the ocular media. Invest Ophthalmol 1962;1:776-781.
14. Wollensak G, Spoerl E, Reber F, et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophtalmic Res 2003;35:324-328.
15. Mazzotta C, Traversi C, Baiocchi S, et al. Conservative treatment of keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: Qualitative investigation. Eur J Ophthalmol 2006;16:530-535.